Innovative biomaterials for regenerative medicine

Volumina Medical is at the forefront of developing innovative biomaterials aimed at addressing significant challenges in regenerative medicine, particularly in the fields of reconstructive and plastic surgery. Their flagship product, AdiPearl™, is designed to facilitate the regeneration of soft tissue volumes that may be lost due to trauma, tumor ablation, or aging. This technology allows for a minimally invasive injection procedure that not only mimics the softness and structure of natural tissue but also enables effective shaping upon injection. The company has garnered recognition for its disruptive technology, which has shown promising long-term preclinical and clinical evidence, indicating its potential to revolutionize treatment methods in aesthetic medicine.

The development of AdiPearl™ is supported by rigorous research conducted at the Swiss Federal Institute of Technology Lausanne (EPFL), highlighting the company's commitment to scientific excellence. Volumina Medical has received significant backing, including a grant from Innosuisse Swiss Accelerator, which will aid in scaling production and advancing their innovative biomaterials. This support underscores the high market potential of their solutions and positions Volumina Medical as a key player in the evolution of regenerative therapies for soft tissue repair.

Switzerland

Volumina Medical is a multi-award-winning start-up active in the field of medical devices supported by a solid network of investors. The company develops breakthrough innovations for plastic and reconstructive surgery. The first product is an implantable polymeric biomaterial and targets the regeneration of soft tissue of the human body which are damaged after tumor excision, genetic malformation or trauma.

Volumina Medical

Company Details